Tumour, Residual
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC (NCT05637580) | Guangdong Provincial People's Hospital | 2019-05-20 |
Track Tumour, Residual automatically
Every clearance here is in the API, with alerts when new ones post.